Cargando…

A Qualitative and Quantitative Assessment of Fundus Autofluorescence Patterns in Patients With Choroideremia

PURPOSE: We set out to characterize the pattern of fundus autofluorescence (AF) loss in choroideremia (CHM) patients of varying ages and disease severity in order to determine the average rate of progression of this potential disease biomarker. METHODS: Fifty consecutive CHM patients (100 eyes) atte...

Descripción completa

Detalles Bibliográficos
Autores principales: Jolly, Jasleen K., Edwards, Thomas L., Moules, Jonathan, Groppe, Markus, Downes, Susan M., MacLaren, Robert E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860725/
https://www.ncbi.nlm.nih.gov/pubmed/27750291
http://dx.doi.org/10.1167/iovs.15-18362
_version_ 1783307989431615488
author Jolly, Jasleen K.
Edwards, Thomas L.
Moules, Jonathan
Groppe, Markus
Downes, Susan M.
MacLaren, Robert E.
author_facet Jolly, Jasleen K.
Edwards, Thomas L.
Moules, Jonathan
Groppe, Markus
Downes, Susan M.
MacLaren, Robert E.
author_sort Jolly, Jasleen K.
collection PubMed
description PURPOSE: We set out to characterize the pattern of fundus autofluorescence (AF) loss in choroideremia (CHM) patients of varying ages and disease severity in order to determine the average rate of progression of this potential disease biomarker. METHODS: Fifty consecutive CHM patients (100 eyes) attending outpatient clinics at Oxford Eye Hospital underwent analysis with the Heidelberg OCT Spectralis with autofluorescence capabilities. The area of residual AF was traced using Heidelberg Eye Explorer. Bland-Altman analysis was used to calculate the coefficient of repeatability (CR). The degree of AF loss was correlated to different ages and the pattern of residual AF constructed into color-coded maps in order to gain insight into the mechanism of disease progression. RESULTS: The CR for measurement of AF area is <1%, indicating that a small change is likely to be significant. Correlation of patient age and area of residual AF produced a clinically relevant index of expected anatomic disease. Progression is 7.7% of the residual area each year (95% confidence intervals 7.0%–8.2%) and follows a logarithmic pattern with age (r = 0.95, P < 0.001). From this we derived the mean half-life of AF as 9 years. Qualitatively, the pattern of remaining AF centered on a point temporal to the fovea. CONCLUSIONS: The area of residual AF in CHM can be measured reproducibly and shows a distinct pattern of loss. The measured residual area is inversely correlated to age. The ratio of the two variables may provide useful information regarding the rate of progression for any one individual at a given point in time.
format Online
Article
Text
id pubmed-5860725
institution National Center for Biotechnology Information
language English
publishDate 2016
record_format MEDLINE/PubMed
spelling pubmed-58607252018-03-20 A Qualitative and Quantitative Assessment of Fundus Autofluorescence Patterns in Patients With Choroideremia Jolly, Jasleen K. Edwards, Thomas L. Moules, Jonathan Groppe, Markus Downes, Susan M. MacLaren, Robert E. Invest Ophthalmol Vis Sci Article PURPOSE: We set out to characterize the pattern of fundus autofluorescence (AF) loss in choroideremia (CHM) patients of varying ages and disease severity in order to determine the average rate of progression of this potential disease biomarker. METHODS: Fifty consecutive CHM patients (100 eyes) attending outpatient clinics at Oxford Eye Hospital underwent analysis with the Heidelberg OCT Spectralis with autofluorescence capabilities. The area of residual AF was traced using Heidelberg Eye Explorer. Bland-Altman analysis was used to calculate the coefficient of repeatability (CR). The degree of AF loss was correlated to different ages and the pattern of residual AF constructed into color-coded maps in order to gain insight into the mechanism of disease progression. RESULTS: The CR for measurement of AF area is <1%, indicating that a small change is likely to be significant. Correlation of patient age and area of residual AF produced a clinically relevant index of expected anatomic disease. Progression is 7.7% of the residual area each year (95% confidence intervals 7.0%–8.2%) and follows a logarithmic pattern with age (r = 0.95, P < 0.001). From this we derived the mean half-life of AF as 9 years. Qualitatively, the pattern of remaining AF centered on a point temporal to the fovea. CONCLUSIONS: The area of residual AF in CHM can be measured reproducibly and shows a distinct pattern of loss. The measured residual area is inversely correlated to age. The ratio of the two variables may provide useful information regarding the rate of progression for any one individual at a given point in time. 2016-08-01 /pmc/articles/PMC5860725/ /pubmed/27750291 http://dx.doi.org/10.1167/iovs.15-18362 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Article
Jolly, Jasleen K.
Edwards, Thomas L.
Moules, Jonathan
Groppe, Markus
Downes, Susan M.
MacLaren, Robert E.
A Qualitative and Quantitative Assessment of Fundus Autofluorescence Patterns in Patients With Choroideremia
title A Qualitative and Quantitative Assessment of Fundus Autofluorescence Patterns in Patients With Choroideremia
title_full A Qualitative and Quantitative Assessment of Fundus Autofluorescence Patterns in Patients With Choroideremia
title_fullStr A Qualitative and Quantitative Assessment of Fundus Autofluorescence Patterns in Patients With Choroideremia
title_full_unstemmed A Qualitative and Quantitative Assessment of Fundus Autofluorescence Patterns in Patients With Choroideremia
title_short A Qualitative and Quantitative Assessment of Fundus Autofluorescence Patterns in Patients With Choroideremia
title_sort qualitative and quantitative assessment of fundus autofluorescence patterns in patients with choroideremia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860725/
https://www.ncbi.nlm.nih.gov/pubmed/27750291
http://dx.doi.org/10.1167/iovs.15-18362
work_keys_str_mv AT jollyjasleenk aqualitativeandquantitativeassessmentoffundusautofluorescencepatternsinpatientswithchoroideremia
AT edwardsthomasl aqualitativeandquantitativeassessmentoffundusautofluorescencepatternsinpatientswithchoroideremia
AT moulesjonathan aqualitativeandquantitativeassessmentoffundusautofluorescencepatternsinpatientswithchoroideremia
AT groppemarkus aqualitativeandquantitativeassessmentoffundusautofluorescencepatternsinpatientswithchoroideremia
AT downessusanm aqualitativeandquantitativeassessmentoffundusautofluorescencepatternsinpatientswithchoroideremia
AT maclarenroberte aqualitativeandquantitativeassessmentoffundusautofluorescencepatternsinpatientswithchoroideremia
AT jollyjasleenk qualitativeandquantitativeassessmentoffundusautofluorescencepatternsinpatientswithchoroideremia
AT edwardsthomasl qualitativeandquantitativeassessmentoffundusautofluorescencepatternsinpatientswithchoroideremia
AT moulesjonathan qualitativeandquantitativeassessmentoffundusautofluorescencepatternsinpatientswithchoroideremia
AT groppemarkus qualitativeandquantitativeassessmentoffundusautofluorescencepatternsinpatientswithchoroideremia
AT downessusanm qualitativeandquantitativeassessmentoffundusautofluorescencepatternsinpatientswithchoroideremia
AT maclarenroberte qualitativeandquantitativeassessmentoffundusautofluorescencepatternsinpatientswithchoroideremia